Armata Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Armata Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Armata Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $43.7M, a 0.04% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $43.7M +$19K +0.04% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $44.2M +$1.42M +3.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $44.7M +$1.68M +3.91% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $44.9M +$10.2M +29.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $43.7M +$8.63M +24.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $42.8M +$7.41M +20.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $43M +$7.18M +20% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $34.6M +$24.1M +229% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $35M +$24.4M +230% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $35.4M +$24.7M +231% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $35.9M +$25.1M +232% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $10.5M -$338K -3.11% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $10.6M -$342K -3.12% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $10.7M +$8.86M +482% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $10.8M +$8.76M +432% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $10.9M +$8.61M +381% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $11M +$8.26M +306% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.84M +$1.55M +543% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $2.03M Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.26M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.7M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $286K Mar 31, 2019 10-Q 2019-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.